Purple Biotech Ltd
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 27.5% | 27.5% | 25.4% |
| FY2022 | -46.2% | -46.2% | -39.7% |
| FY2023 | -58.1% | -58.1% | -44.9% |
| FY2024 | -22.0% | -22.0% | -19.5% |
| FY2025 | -271.6% | -271.6% | -150.2% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 27.5% | 27.5% | 25.4% |
| FY2022 | -46.2% | -46.2% | -39.7% |
| FY2023 | -58.1% | -58.1% | -44.9% |
| FY2024 | -22.0% | -22.0% | -19.5% |
| FY2025 | -271.6% | -271.6% | -150.2% |